Changing epidemiology of HIV-associated cryptococcosis in sub-Saharan Africa.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
   Pooled it
2. Treatment for HIV-associated cryptococcal meningitis.The Cochrane database of systematic reviews · 2018
   Pooled it
3. Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014-2015.African journal of laboratory medicine · 2020
   Article
4. Reply to Rajasingham and Boulware.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
   Article
5. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study.Scientific reports · 2019
   Observational
6. Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia.Open forum infectious diseases · 2019
   Article
7. Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil.PloS one · 2019
   Article
8. High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B-Based Therapy Under Routine Care Conditions in Africa.Open forum infectious diseases · 2018
   Article
9. Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation.Open forum infectious diseases · 2018
   Article
10. The epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2018
    Review
11. Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
12. The CSF Immune Response in HIV-1-Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy.Journal of acquired immune deficiency syndromes (1999) · 2017
    Article
13. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Expert review of anti-infective therapy · 2017
    Review

Corrections and comments

• Comment on
  Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.2016

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as